Andrew Brunner
Assistant Professor, Medicine at Harvard Medical School
Schools
- Harvard Medical School
Links
Biography
Harvard Medical School
Myelodysplastic syndromes are disorders of the bone marrow associated with bone marrow failure and a risk of progression to acute myeloid leukemia. My clinical area of focus and research projects are focused toward understanding treatment patterns and patient outcomes in MDS and other advanced hematologic malignancies, and to develop new treatments for these patients. The therapies available for patients with MDS have not changed in the last decade, and there is critical need to develop new agents and identify the patients most likely to benefit from a given chemotherapy. I am involved in clinical trials for all stages of MDS with an overall goal of tailoring treatment to improve the outcomes of these patients.
Departments, Centers, & Programs:
- Hematology/Oncology
Clinical Interests:
- Acute and Chronic Leukemia
- Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia
- Chronic myeloid leukemia
- Myelodysplasia
- Myelodysplastic syndrome (MDS)
- Myeloproliferative neoplasms
Medical Education
- MD, Warren Alpert Medical School of Brown University
- Residency, Massachusetts General Hospital
- Fellowship, Brigham and Women's Hospital
- Fellowship, Dana Farber Cancer Institute
- Fellowship, Dana Farber Cancer Institute
American Board Certifications
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Videos
What treatment would you suggest for high risk MDS patients not fit for chemotherapy or HSCT?
Antibody therapies for AML and MDS
Evaluating therapies in MDS
Managing the progression of MDS to AML
The treatment protocol for higher risk MDS
Benefits of a virtual EHA 2021 meeting
Novel therapies on the horizon for MDS
Sabatolimab plus HMAs in high-/very high-risk MDS and ND-AML
Read about executive education
Other experts
Popular Courses
Private Equity: Investing and Creating Value
The Wharton School
Philadelphia, Pennsylvania, United States
Feb 2, 2025
The Positive Leader: Deep Change and Organizational Transformation
Stephen M. Ross School of Business
Ann Arbor, Michigan, United States
Sep 29
Leading People and Teams
ESMT
Berlin, Germany
Nov 19
Looking for an expert?
Contact us and we'll find the best option for you.